321 related articles for article (PubMed ID: 8031148)
1. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
Kawaji K; Matsunaga Y; Kido H; Ogura T
Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
[TBL] [Abstract][Full Text] [Related]
3. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
He S; Gaça MD; McEuen AR; Walls AF
J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
[TBL] [Abstract][Full Text] [Related]
5. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
[TBL] [Abstract][Full Text] [Related]
6. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes.
Vliagoftis H; Lacy P; Luy B; Adamko D; Hollenberg M; Befus D; Moqbel R
Int Arch Allergy Immunol; 2004 Nov; 135(3):196-204. PubMed ID: 15467372
[TBL] [Abstract][Full Text] [Related]
7. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of degranulation from human eosinophils by platelet-activating factor.
Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction.
Matsunaga Y; Shono M; Takahashi M; Tsuboi Y; Ogawa K; Yamada T
Br J Pharmacol; 2000 Aug; 130(7):1539-46. PubMed ID: 10928955
[TBL] [Abstract][Full Text] [Related]
10. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
[TBL] [Abstract][Full Text] [Related]
11. Biological functions of serine proteases in mast cells in allergic inflammation.
Katunuma N; Kido H
J Cell Biochem; 1988 Dec; 38(4):291-301. PubMed ID: 2467915
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
He SH; Chen HQ; Zheng J
Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
[TBL] [Abstract][Full Text] [Related]
14. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
Kido H; Fukusen N; Katunuma N
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():95-100. PubMed ID: 2462436
[TBL] [Abstract][Full Text] [Related]
15. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.
Khalife J; Capron M; Grzych JM; Bazin H; Capron A
J Immunol; 1985 Mar; 134(3):1968-74. PubMed ID: 3968436
[TBL] [Abstract][Full Text] [Related]
16. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
17. Identification of a chymotrypsin-like proteinase in human mast cells.
Schechter NM; Choi JK; Slavin DA; Deresienski DT; Sayama S; Dong G; Lavker RM; Proud D; Lazarus GS
J Immunol; 1986 Aug; 137(3):962-70. PubMed ID: 2424994
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
20. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]